@prefix fhir: <http://hl7.org/fhir/> .
@prefix loinc: <https://loinc.org/rdf/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://prostatecancerspec.org/Observation/TransurethralEnucleationDiagnosticConclusionGrouper> a fhir:Observation ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "TransurethralEnucleationDiagnosticConclusionGrouper"] ; # 
  fhir:meta [
     fhir:profile ( [
       fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper|2026.0.0"^^xsd:anyURI ;
       fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper?version=2026.0.0>
     ] )
  ] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Observation TransurethralEnucleationDiagnosticConclusionGrouper</b></p><a name=\"TransurethralEnucleationDiagnosticConclusionGrouper\"> </a><a name=\"hcTransurethralEnucleationDiagnosticConclusionGrouper\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper\">MII PR Patho Diagnostic Conclusion Grouperversion: null2026.0.0)</a></p></div><p><b>basedOn</b>: <a href=\"ServiceRequest-TransurethralEnucleationReportRequest.html\">ServiceRequest Simple prostatectomy (procedure)</a></p><p><b>status</b>: Final</p><p><b>category</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}\">Laboratory</span></p><p><b>code</b>: <span title=\"Codes:{http://loinc.org 22637-3}\">Pathology report final diagnosis Narrative</span></p><p><b>subject</b>: <a href=\"Patient-Patient3.html\">Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)</a></p><p><b>effective</b>: 2024-05-12</p><p><b>performer</b>: <a href=\"Practitioner-PathologistPractitioner.html\">Practitioner Maria Schneider </a></p><p><b>note</b>: By Practitioner/PathologistPractitioner @2024-05-12</p><blockquote><div><p>Zusammenfassung: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) mit invasiven kribriformen Anteilen und intraduktaler Karzinomkomponente. Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Prozentualer Anteil Gleasonmuster 4 und 5: 90%. Ausgedehnte Tumorinfiltration, ca. 60% des Prostatagewebes befallen. Extraprostatische Ausbreitung nachgewiesen. Samenblaseninfiltration nachgewiesen. Lymphovaskuläre Invasion nachgewiesen. Perineurale Infiltration nachgewiesen. Empfehlung: Staging-Untersuchungen und interdisziplinäre Tumorkonferenz.</p>\n</div></blockquote><p><b>hasMember</b>: </p><ul><li><a href=\"Observation-TransurethralEnucleationHistologicalTypeICDO3.html\">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href=\"Observation-TransurethralEnucleationMorphologyFreeText.html\">Observation Histology type in Cancer specimen Narrative</a></li><li><a href=\"Observation-TransurethralEnucleationPrimaryGleasonPattern.html\">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href=\"Observation-TransurethralEnucleationSecondaryGleasonPattern.html\">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href=\"Observation-TransurethralEnucleationGleasonScoreTotal.html\">Observation Gleason score in Specimen Qualitative</a></li><li><a href=\"Observation-TransurethralEnucleationPercentageGleason45.html\">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area</a></li><li><a href=\"Observation-TransurethralEnucleationGradingGroupISUP.html\">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href=\"Observation-TransurethralEnucleationIntraductalCarcinoma.html\">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href=\"Observation-TransurethralEnucleationInvasiveCribriformCarcinoma.html\">Observation Invasive cribriform carcinoma (morphologic abnormality)</a></li><li><a href=\"Observation-TransurethralEnucleationProstaticTissueInvolved.html\">Observation Tissue cores.positive.carcinoma in Tissue core</a></li><li><a href=\"Observation-TransurethralEnucleationExtraprostaticExtension.html\">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href=\"Observation-TransurethralEnucleationSeminalVesicleInvasion.html\">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href=\"Observation-TransurethralEnucleationLymphovascularInvasion.html\">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href=\"Observation-TransurethralEnucleationPerineuralInfiltration.html\">Observation Perineural invasion [Presence] in Cancer specimen</a></li></ul><p><b>derivedFrom</b>: <a href=\"QuestionnaireResponse-QuestionnaireResponseTransurethralEnucleation.html\">Response to Questionnaire 'https://art-decor.org/fhir/Questionnaire/2.16.840.1.113883.3.1937.777.18.27.20--20250115134435' about '-&gt;Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)'</a></p></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:basedOn ( [
     fhir:l <http://prostatecancerspec.org/ServiceRequest/TransurethralEnucleationReportRequest> ;
     fhir:reference [ fhir:v "ServiceRequest/TransurethralEnucleationReportRequest" ]
  ] ) ; # 
  fhir:status [ fhir:v "final"] ; # 
  fhir:category ( [
     fhir:coding ( [
       fhir:system [
         fhir:v "http://terminology.hl7.org/CodeSystem/observation-category"^^xsd:anyURI ;
         fhir:l <http://terminology.hl7.org/CodeSystem/observation-category>
       ] ;
       fhir:code [ fhir:v "laboratory" ]
     ] )
  ] ) ; # 
  fhir:code [
     fhir:coding ( [
       a loinc:22637-3 ;
       fhir:system [
         fhir:v "http://loinc.org"^^xsd:anyURI ;
         fhir:l <http://loinc.org>
       ] ;
       fhir:code [ fhir:v "22637-3" ]
     ] )
  ] ; # 
  fhir:subject [
     fhir:l <http://prostatecancerspec.org/Patient/Patient3> ;
     fhir:reference [ fhir:v "Patient/Patient3" ]
  ] ; # 
  fhir:effective [
     a fhir:DateTime ;
     fhir:v "2024-05-12"^^xsd:date
  ] ; # 
  fhir:performer ( [
     fhir:l <http://prostatecancerspec.org/Practitioner/PathologistPractitioner> ;
     fhir:reference [ fhir:v "Practitioner/PathologistPractitioner" ]
  ] ) ; # 
  fhir:note ( [
     fhir:author [
       a fhir:Reference ;
       fhir:l <http://prostatecancerspec.org/Practitioner/PathologistPractitioner> ;
       fhir:reference [ fhir:v "Practitioner/PathologistPractitioner" ]
     ] ;
     fhir:time [ fhir:v "2024-05-12"^^xsd:date ] ;
     fhir:text [ fhir:v "Zusammenfassung: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) mit invasiven kribriformen Anteilen und intraduktaler Karzinomkomponente. Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Prozentualer Anteil Gleasonmuster 4 und 5: 90%. Ausgedehnte Tumorinfiltration, ca. 60% des Prostatagewebes befallen. Extraprostatische Ausbreitung nachgewiesen. Samenblaseninfiltration nachgewiesen. Lymphovaskuläre Invasion nachgewiesen. Perineurale Infiltration nachgewiesen. Empfehlung: Staging-Untersuchungen und interdisziplinäre Tumorkonferenz." ]
  ] ) ; # 
  fhir:hasMember ( [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationHistologicalTypeICDO3> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationHistologicalTypeICDO3" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationMorphologyFreeText> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationMorphologyFreeText" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationPrimaryGleasonPattern> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationPrimaryGleasonPattern" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationSecondaryGleasonPattern> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationSecondaryGleasonPattern" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationGleasonScoreTotal> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationGleasonScoreTotal" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationPercentageGleason45> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationPercentageGleason45" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationGradingGroupISUP> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationGradingGroupISUP" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationIntraductalCarcinoma> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationIntraductalCarcinoma" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationInvasiveCribriformCarcinoma> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationInvasiveCribriformCarcinoma" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationProstaticTissueInvolved> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationProstaticTissueInvolved" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationExtraprostaticExtension> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationExtraprostaticExtension" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationSeminalVesicleInvasion> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationSeminalVesicleInvasion" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationLymphovascularInvasion> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationLymphovascularInvasion" ]
  ] [
     fhir:l <http://prostatecancerspec.org/Observation/TransurethralEnucleationPerineuralInfiltration> ;
     fhir:reference [ fhir:v "Observation/TransurethralEnucleationPerineuralInfiltration" ]
  ] ) ; # 
  fhir:derivedFrom ( [
     fhir:l <http://prostatecancerspec.org/QuestionnaireResponse/QuestionnaireResponseTransurethralEnucleation> ;
     fhir:reference [ fhir:v "QuestionnaireResponse/QuestionnaireResponseTransurethralEnucleation" ]
  ] ) . # 

# -------------------------------------------------------------------------------------

